COMPASS Pathways clinical trials we track

Check company identity source

Phase 3 2 trials

TrialDrugs studiedStatusPrimary completion
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940PsilocybinActive not recruiting2025-11-13Actual
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268PsilocybinCompleted2025-05-28Actual

Phase 2 / 3 1 trial

Phase 2 4 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 255 participants (planned). After: 258 participants (actual).

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source